These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16508724)

  • 41. The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis.
    Jumaah AS; Al-Haddad HS; McAllister KA; Yasseen AA
    PLoS One; 2022; 17(2):e0263585. PubMed ID: 35139130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endometrial metastasis of colorectal cancer with coincident endometrial adenocarcinoma.
    Colling R; Lopes T; Das N; Mathew J
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB.
    Han KH; Kim HS; Lee M; Chung HH; Song YS
    Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endometrial adenocarcinoma: current status and future of prevention and early diagnosis.
    Jiménez-Ayala M; Jiménez-Ayala Portillo B
    Monogr Clin Cytol; 2011; 20():52-59. PubMed ID: 21160248
    [No Abstract]   [Full Text] [Related]  

  • 47. [Endometrial cancer, turned out to be an endometroid ovarian cancer stage II].
    Lazarov N; Lazarov L; Laarov S; Velev V; Ananiev J
    Akush Ginekol (Sofiia); 2011; 50(6):48-50. PubMed ID: 22452068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular profiles of benign and (pre)malignant endometrial lesions.
    van der Putten LJM; van Hoof R; Tops BBJ; Snijders MPLM; van den Berg-van Erp SH; van der Wurff AAM; Bulten J; Pijnenborg JMA; Massuger LFAG
    Carcinogenesis; 2017 Mar; 38(3):329-335. PubMed ID: 28203752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
    Wu W; Lin Z; Zhuang Z; Liang X
    Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
    Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
    Soovares P; Pasanen A; Bützow R; Lassus H
    Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilization of unlabeled probes for the detection of fibroblast growth factor receptor 2 exons 7 and 12 mutations in endometrial carcinoma.
    Liu T; Willmore-Payne C; Wallander ML; Layfield LJ
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):341-6. PubMed ID: 21285871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
    Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
    Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunohistochemical and molecular pathological typing in the differential diagnosis and prognosis risk assessment of endometrial carcinoma].
    Wang MH; Hui P
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1078-1082. PubMed ID: 34496509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current concepts in the pathology and epigenetics of endometrial carcinoma.
    Arafa M; Somja J; Dehan P; Kridelka F; Goffin F; Boniver J; Delvenne P
    Pathology; 2010 Dec; 42(7):613-7. PubMed ID: 21080868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial Cancer: An Update on Prognostic Pathologic Features and Clinically Relevant Biomarkers.
    Li JJX; Ip PPC
    Surg Pathol Clin; 2022 Jun; 15(2):277-299. PubMed ID: 35715162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SEOM guidelines for endometrial cancer.
    Oaknin A; Rodríguez-Freixinós V; Díaz de Corcuera I; Rivera F; del Campo JM;
    Clin Transl Oncol; 2012 Jul; 14(7):512-5. PubMed ID: 22721795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
    Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
    J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic analysis of two sister pairs with endometrial cancer.
    Liu GB; Pang ZJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):239-40. PubMed ID: 15759345
    [No Abstract]   [Full Text] [Related]  

  • 60. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.
    Garg K; Soslow RA
    Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.